Search research articles
Contact Us
Filters
Showing results (31-40 of 56) with videos related to
Page
of 6
Sort By:
Haematologica
|
May 21, 1998
Factors affecting hemopoietic recovery after high-dose therapy and autologous peripheral blood progenitor cell transplantation: a single center experience
A Olivieri, M Offidani, M Montanari, et al.
Haematologica
|
May 16, 1998
Two dosage interferon-alpha 2b maintenance therapy in patients affected by low-risk multiple myeloma in plateau phase: a randomized trial
M Offidani, A Olivieri, M Montillo, et al.
British Journal of Haematology
|
September 6, 2000
Amifostine can reduce mucosal damage after high-dose melphalan conditioning for peripheral blood progenitor cellautotransplant: a retrospective study
D Capelli, G Santini, C De Souza, et al.
The Journal of Investigative Dermatology
|
November 9, 2000
Carboxyfullerenes protect human keratinocytes from ultraviolet-B-induced apoptosis
C Fumelli, A Marconi, S Salvioli, et al.
Bone Marrow Transplantation
|
April 5, 2016
Italian consensus conference for the outpatient autologous stem cell transplantation management in multiple myeloma
M Martino, R M Lemoli, C Girmenia, et al.
The British Journal of Dermatology
|
May 9, 2007
Differences in survivin location and Bcl-2 expression in CD30+ lymphoproliferative disorders of the skin compared with systemic anaplastic large cell lymphomas: an immunohistochemical study
G Goteri, O Simonetti, S Rupoli, et al.
Bone Marrow Transplantation
|
August 10, 2004
Combined administration of alpha-erythropoietin and filgrastim can improve the outcome and cost balance of autologous stem cell transplantation in patients with lymphoproliferative disorders
A Olivieri, I Scortechini, D Capelli, et al.
The Journal of Dermatological Treatment
|
January 16, 2018
Secukinumab in multi-failure psoriatic patients: the last hope?
M Magnano, C Loi, A Patrizi, et al.
Medical Mycology
|
December 31, 2008
In vitro susceptibility of dermatophytes to conventional and alternative antifungal agents
Francesco Barchiesi, Carmela Silvestri, Daniela Arzeni, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 22, 2011
Previous thalidomide therapy may not affect lenalidomide response and outcome in relapse or refractory multiple myeloma patients
T Guglielmelli, S Bringhen, S Rrodhe, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 56) with videos related to
Sort By:
Page
of 6
Haematologica
|
May 21, 1998
Factors affecting hemopoietic recovery after high-dose therapy and autologous peripheral blood progenitor cell transplantation: a single center experience
A Olivieri, M Offidani, M Montanari, et al.
Haematologica
|
May 16, 1998
Two dosage interferon-alpha 2b maintenance therapy in patients affected by low-risk multiple myeloma in plateau phase: a randomized trial
M Offidani, A Olivieri, M Montillo, et al.
British Journal of Haematology
|
September 6, 2000
Amifostine can reduce mucosal damage after high-dose melphalan conditioning for peripheral blood progenitor cellautotransplant: a retrospective study
D Capelli, G Santini, C De Souza, et al.
The Journal of Investigative Dermatology
|
November 9, 2000
Carboxyfullerenes protect human keratinocytes from ultraviolet-B-induced apoptosis
C Fumelli, A Marconi, S Salvioli, et al.
Bone Marrow Transplantation
|
April 5, 2016
Italian consensus conference for the outpatient autologous stem cell transplantation management in multiple myeloma
M Martino, R M Lemoli, C Girmenia, et al.
The British Journal of Dermatology
|
May 9, 2007
Differences in survivin location and Bcl-2 expression in CD30+ lymphoproliferative disorders of the skin compared with systemic anaplastic large cell lymphomas: an immunohistochemical study
G Goteri, O Simonetti, S Rupoli, et al.
Bone Marrow Transplantation
|
August 10, 2004
Combined administration of alpha-erythropoietin and filgrastim can improve the outcome and cost balance of autologous stem cell transplantation in patients with lymphoproliferative disorders
A Olivieri, I Scortechini, D Capelli, et al.
The Journal of Dermatological Treatment
|
January 16, 2018
Secukinumab in multi-failure psoriatic patients: the last hope?
M Magnano, C Loi, A Patrizi, et al.
Medical Mycology
|
December 31, 2008
In vitro susceptibility of dermatophytes to conventional and alternative antifungal agents
Francesco Barchiesi, Carmela Silvestri, Daniela Arzeni, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 22, 2011
Previous thalidomide therapy may not affect lenalidomide response and outcome in relapse or refractory multiple myeloma patients
T Guglielmelli, S Bringhen, S Rrodhe, et al.
Page
of 6